Inventor
James A. Williams
Inventor
Lincoln, NE, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes26%
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides19%
Y02ATechnologies for adaptation to climate change12%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture10%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
10,844,388Replicative minicircle vectors with improved expression202010,167,478Replicative minicircle vectors with improved expression201910,144,935DNA plasmids with improved expression201810,047,365Replicative minicircle vectors with improved expression20189,950,081Vectors and methods for genetic immunization20189,951,368Methods of DNA constructs for high yield production of polypeptides20189,737,620'Vectors and methods for genetic immunization'20179,725,725'E. coli plasmid DNA production'20179,550,998'DNA plasmids with improved expression'20179,506,082'Eukaryotic expression vectors resistant to transgene silencing'20169,487,789'E. coli plasmid DNA production'20169,487,788'E. coli plasmid DNA production'20169,322,025'Methods and DNA constructs for high yield production of polypeptides'20169,109,012'Vectors and method for genetic immunization'20159,045,759'DNA plasmids with improved copy number'20159,017,966'E. coli plasmid DNA production'20159,018,012'Vectors and methods for genetic immunization'20159,012,226'Bacterial strains with improved plasmid stability'20158,999,672'Compositions and processes for improved plasmid DNA production'20158,748,168'Strains of E. coli for plasmid DNA production'20147,943,377'Process for plasmid DNA fermentation'20117,501,484'Methods and DNA constructs for high yield production of polypeptides'20096,967,088'Soluble recombinant botulinum toxin proteins'20056,652,857'Methods for producing avian verotoxin antitoxin'20036,613,329'Vaccine and antitoxin for treatment and prevention of C. difficile disease'20036,573,003'Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease'20036,365,158'Methods for producing neutralizing antitoxin to C. difficile toxin B'20026,080,400'Compositions for the prevention and treatment of verotoxin-induced disease'20005,919,665'Vaccine for clostridium botulinum neurotoxin'19995,814,477'Recombinant clostridial toxin protein'19985,762,934'Clostridium difficile toxin disease therapy'19985,601,823'Avian antitoxins to clostridium difficle toxin A'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2000Patents assigned to OPHIDIAN PHARM INC (5)· patent assignee history
1997–2003Based in Madison, WI, US· patent location history
2000–2020Based in Lincoln, NE, US· patent location history
2011–2015Patents assigned to NATURE TECHNOLOGY CORP (6)· patent assignee history
2014–2016Patents assigned to WILLIAMS JAMES A (8)· patent assignee history
2016–2017Patents assigned to NATURE TECH CORP (6)· patent assignee history
2018–2020Patents assigned to NATURE TECH CORPORATION (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WILLIAMS JAMES Aself | 8 | 2014–2016 |
| NATURE TECH CORP | 6 | 2016–2017 |
| NATURE TECHNOLOGY CORP | 6 | 2011–2015 |
| NATURE TECH CORPORATION | 5 | 2018–2020 |
| OPHIDIAN PHARM INC | 5 | 1997–2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lincoln, NE, US | 26 | 2000–2020 |
| Madison, WI, US | 6 | 1997–2003 |